Indonesia Animal Health Market - Strategic Insights and Forecasts (2025-2030)

Description

Indonesia Animal Health Market Size:

The Indonesian Animal Health Market is estimated to attain a market size of USD 793.816 million by 2030, growing at a 4.20% CAGR from a valuation of USD 646.155 million in 2025.

Indonesia Animal Health Market Highlights:

• Driving disease prevention: Vaccines are reducing livestock disease outbreaks effectively.
• Boosting feed additives: Nutritional products are enhancing animal growth, productivity.
• Supporting the poultry sector: Health solutions are meeting the rising poultry demand needs.
• Expanding veterinary services: Clinics are providing essential care for companion animals.
• Promoting government initiatives: Policies are encouraging animal health awareness programs.
• Enhancing farm efficiency: Pharmaceuticals are treating diseases in production animals.
• Growing online distribution: E-commerce is increasing access to health products.

The animal health market in Indonesia is growing steadily, spurred by increasing demand for livestock products and rising government ambition for disease control and food security. Growth in the poultry, cattle, and goat populations is driving the demand for vaccines, diagnostics, feed additives, and veterinary services. Government programs for vaccination and compliance with international health standards, such as WOAH regulations, are promoting disease control. Indonesia has started a vaccination program that addresses the spread of foot-and-mouth disease, which impacted livestock in 11 provinces, affecting over 14,630 animals with 338 deaths as of December. The vaccination program’s objective is to immunise healthy animals to build immunity against disease spread through unvaccinated livestock, increased regional livestock traffic, and extreme weather. The central government has approved 4 million doses for the vaccination program, distributing vaccines in areas with the highest case incidence, which encouraged local authorities on Java Island to prioritise cases within that area. The market benefits from structured public-private partnerships and improved surveillance capabilities, enabling sustainable growth. Animal health is being scaled up by investing in veterinary infrastructure, digital health and biosecurity, driving productivity and the resilience of the livestock sector.

Indonesia Animal Health Market Trends:

Animal health products are all those products that are specifically manufactured to cater to the needs of animals, such as medicines, vaccines, and other nutritional products, among others. The growth in the number of diseases in animals is anticipated to be one of the primary factors supplementing the demand for animal health products globally during the next five years. Similarly, on the other hand, a significant increase in the demand for food and food products has led to an upsurge in the livestock population in the country. This, combined with the rising outbreak of animal diseases, is projected to supplement the market growth during the given time frame.

Furthermore, the government is playing a significant role in bolstering the demand for animal health-related products since they are strategically taking steps to promote the health of animals. A surge in the number of animal welfare associations in a rapid growth in the number of NGOs focusing on the care of stray animals are also propelling the business growth opportunities for the manufacturers over the forecast period. Moreover, an upsurge in animal breeding activities and the growing inclination of millennials towards the adoption of animals also provides an impetus to the market growth in the near future.

The segmentation of the Indonesian animal health market has been done into type, animal type, end-user, distribution channel, and geography. By type, the classification of the market has been done into Vaccines, Pharmaceuticals, Feed Additives, and Others. By animal type, the classification of the market has been done into Companion Animal and Production Animal. By end-user, the classification of the market has been done into Vet Hospitals and Clinics, Animal Farms, and Others. By distribution channel, the classification of the market has been done into Online and Offline.

Indonesia Animal Health Market Overview

The animal health industry in Indonesia is developing alongside the growing livestock and poultry industries. Consumer demand for meat, milk, and eggs is driving herd and flock growth, and government interventions to ensure food security and reduce imports are providing added impetus to this increase. This structural growth will increase demand for veterinary services, vaccines, diagnostics, feed supplements, and biosecurity measures. The most recent Ministry of Agriculture livestock and animal health 2024 statistics indicate that livestock sectors maintain long-term demand for animal health strategies with consistent growth across the poultry, cattle, and goat sectors.

The public animal health service infrastructure is a key factor driving market growth. There is an emphasis on disease control and prevention, with high-priority and emerging animal diseases reportable to WOAH (World Organization for Animal Health), such as Foot-and-mouth disease, Avian Influenza, and transboundary animal diseases, being addressed through the national livestock development program’s workplan. The country needs to ramp up large-scale vaccination programs, veterinary service provision, and effective quarantine requirements to mitigate risks and strengthen production resilience. These programmes will respond to the immediate needs of outbreaks, whilst also investing resources in building a stronger veterinary services sector that will create sustainable demand for vaccine and diagnostic products.

The market opportunity could be further complemented by Indonesia’s alignment with international standards outlined by the WOAH. Capacity-building opportunities and regional workshops, and collaboration have helped to identify and advocate for action to elevate reporting procedures and disease surveillance; this, along with a continuity focus on biosecurity, could position Indonesia for growth in animal health services and consumption of animal health products.

Recent news cycles showcase a growing focus on modernisation and digitalisation in livestock management. The Ministry of Agriculture has been encouraging improvements to the systems of data organisation, collection, and reporting on animal health to provide clearer signals for suppliers and improve policy planning and efficiency. With an ongoing commitment to investing in veterinary services, disease surveillance, and public-private partnership development, Indonesia's animal health economy is projected to continue growing in the next few years.

Zoetis Inc., a global leader in animal health, reported revenues of USD 2,317 million in 2024, up from USD 2,213 million in 2023, reflecting a fourth-quarter year-on-year growth. This increase indicates sustained demand for veterinary products, vaccines, and diagnostics across livestock and companion animals. Rising revenue supports continued investment in research and development, expanded product portfolios, and global distribution channels, which strengthen overall industry capacity. Such growth not only reflects Zoetis’ market leadership but also signals broader expansion in the animal health sector, promoting innovation, better disease management, and improved livestock productivity worldwide.

Indonesia Animal Health Market Growth Drivers:

• Rising awareness of animal health amongst the farmers will be a tailwind to the growth of the market during the forecast period.

The growth of the animal health care market in Indonesia will be further fuelled by its increasing awareness amongst the farmers in the country.  According to a document published by the ReAct Asia-Pacific, the share of antimicrobials used in livestock production in Indonesia is dominantly in poultry farms rather than other livestock sectors. A study of antibiotic use in 360 small and medium-scale commercial broiler farms in three provinces: West Java, East Java, South Sulawesi, by the Ministry of Agriculture revealed the following results:

Most of the farms (86%) operated under a supply contract with a major integrated poultry company. The decision on which antibiotics to use is influenced by the technical staff of the poultry farm supply contract company, who also provide the antibiotics for farmers (75%), followed by farmers’ previous experiences (9%), and sales staff of drug/feed/day-old-chick suppliers (7%). Most farm supply contract company technical staff (86%) and drug/feed/day-old-chick suppliers’ staff (50%) do not have a veterinary background. Most commonly used antibiotics were: Enrofloxacin (49.4%), amoxicillin/colistin (35.3%), trimethoprim/sulfadiazine (14.1%), and doxycycline (13.3%). Such developments are expected to increase the adoption of animal health care solutions in the country.

• Expansion of Livestock Farming    

The growth of livestock production in Indonesia is driven by increasing domestic consumption of animal products (meat, milk, and eggs), causing both small and large agribusinesses to increase production levels and modernize practices. With rising incomes and an urbanizing diet that includes more animal protein, growers are abandoning traditional low-output systems for more intensive and commercially organized systems. Growth in poultry and cattle production has been particularly rapid, driven by contract farming and better access to veterinary inputs and government action to support food self-sufficiency. 

In Indonesia, there were 676 poultry establishments in 2023, 562 in 2022, and 385 in 2021, according to the 2024 report of BPS - Statistics Indonesia. Emerging hubs for production and investment, such as areas with strong agricultural infrastructure in Java and parts of Sumatra and Sulawesi, are triggering investment in feed mills, breeding facilities, animal health services, and cold chain logistics. Concurrently, as production practices intensify, demand for vaccines, antibiotics, diagnostics, and herd health management solutions to reduce mortality and enhance productivity is increasing.

The government has been instrumental in promoting livestock farming in Indonesia, driven by productivity, disease control, and security of domestic supply. Programs from the Ministry of Agriculture, such as Sapi Indukan Wajib Bunting (SIWAB), were integrated to promote national cattle stock, primarily through artificial insemination and, ultimately, widely available breeding support. The government has also implemented import regulations and quotas to limit transfer dependence and to prioritize locally produced livestock carcasses. The Beef Self-Sufficiency Program and National Broiler Development Strategy are integrated, facilitating investment in modern facilities for livestock farming or training for farmers to aid in sustainable investment diets and available feed supplies. 

Indonesia Animal Health Market Segmentation Analysis

• By Type: Vaccine

By type, the Indonesian animal health market is segmented into vaccines, pharmaceuticals, feed additives, and others. Vaccines represent one of the most important areas of animal health in Indonesia, especially as farmers are shifting from reacting to diseases through treatment to preventing diseases through vaccination. With intensification, production and animal densities are expanding, increasing the risk of a contagious disease, making effective vaccine a cost-effective method of maintaining herd health and ensuring stable production. Furthermore, the use of public vaccines for regionally important diseases like foot-and-mouth disease, avian influenza, and classical swine fever is significant in establishing baseline immunity levels and awareness (and later commercial demand) for vaccine products. 

Indonesia has initiated a vaccination campaign to control an outbreak of foot-and-mouth disease, which has spread to 11 provinces and infected thousands of animals. National animal health information system data indicated that 338 livestock have died and approximately 14,630 others have been infected since foot-and-mouth disease was first noted in December 2024. Indonesia has distributed 124,225 doses of a foot-and-mouth disease (FMD) vaccine in the first phase of distribution to contain the spread of the disease among livestock. In 2025, the Ministry of Agriculture is preparing an additional 4 million doses of vaccine to distribute to 25 provinces with foot-and-mouth disease on a staggered basis.

Vaccine products are considered as biological products, which are under the broader category of veterinary medicinal products. Products in this category must meet stringent requirements for safety, efficacy, and quality before they may enter the market. The primary regulatory instrument is Government Regulation No. 78 of 1992 on veterinary medicines, which states that only registered veterinary medicines may be produced and sold, specifies packaging and labeling requirements, and authorizes the government to periodically assess the quality of the products available on the market.            

• By Animal Type: Companion Animal

By animal type, the Indonesian animal health market is segmented into companion animals and production animals. The rise in demand for companion animals is attributed to rapidly increasing urbanization and industrialization. According to the World Bank data on the country’s urban population, around 167.836 million individuals are living in urban regions in 2024, an increase from 161.538 million in 2022. This growth in urbanization will promote the higher adoption of companion animals among urban dwellers, along with driving the demand for animal vaccines, antibodies, and diagnostics, among others, in the region.

Pet humanization has become a popular trend among Indonesian nuclear families. This was further bolstered by the growing number of single individuals choosing to have a pet. The data from the Health for Animals Organization of 2022 stated that more than half of the population globally is predicted to have a pet in the form of a cat, dog, or other animals at home. This suggests a rise in the adoption of animals as companion animals in the country.

Consumer demand for safe and nutritious food, along with rising government pressure to develop modern systems for animal health management, has contributed to the industry's expansion in demand for farm and animal health products. As pet owners become increasingly health-conscious, consumers are demanding clearly defined clean labels. Furthermore, Indonesian pet owners are adamant about learning about the nutritional components of numerous animal care products.

Moreover, as people become more concerned about their pet's health, particularly regarding their food, the pet owners are increasingly focused on their pet's meals. They also have a strong preference for natural and organic products. Pet owners who are highly devoted to their animals frequently spend significant amounts on pet food and other animal care products.

In addition to this, a rise in the number of animal welfare organizations, along with significant developments in the number of NGOs focusing on the care of stray animals, is accelerating commercial growth prospects for manufacturers. Furthermore, an increase in animal breeding operations, as well as millennials' growing preference for animal adoption, will fuel market expansion in the near future. For instance, in September 2025, the Government officials, veterinarians, NGOs, academics, and community representatives in Indonesia gathered for the workshop, which was “Act Now: You, Me and the Community” and World Rabies Day, and announced the launch of the ‘Better Animal Welfare, Healthier Communities NTT 2025 Program’. Under this program, it plans to promote the training of vaccinators to utilize Humane World for tracking rabies vaccination and animal health.

In comparison to canines, there is a bigger cat population in the country. In convenience-oriented animal health care industries, the rise in internet sales and the growth of e-commerce are accelerating the pet owners’ access to OTC pet medications, prescription fulfillment, and other health care for their companion animals, thereby promoting this segment. For instance, according to the report of the United Nations Economic and Social Commission for Asia and the Pacific (UN ESCAP), the Indonesian e-commerce market users were estimated to increase from 48.2 million in 2023 to about 244.67 million users by 2027, a growth of 24.53%.

• By End-user: Animal Farm

By end user, the Indonesian animal health market is categorized into vet hospitals and clinics, animal farms, and others. Indonesia is one of the leading livestock trading countries in the ASEAN region. The robust trade of livestock and meat, coupled with significant demand for poultry, dairy, and other farm products, makes the animal husbandry industry a lucrative market, attracting notable players and investment.

With the rise in animal husbandry, the farm industry is also creating a significant demand for animal health for better productivity and quality, hence driving market expansion. For instance, the government's latest program, the ‘Free Nutritious Meals Program’, focuses on providing milk to more than 82 million beneficiaries daily by 2029. The new government administration is also expected to promote growth in milk production by importing about 1 million dairy cattle from various countries within the next five years.

Moreover, milk production in the country is witnessing growth from 672,000 million tons (MT) per year in 2023 to 699,000 MT/year in 2025, according to the United States Department of Agriculture (USDA). This will encourage the animal farmer's necessity for preventive medications like vaccinations and deworming health products, diagnostics, quarantine services, and mandatory health certifications of cattle and their health management, which will grow the market significantly in the years to come.

Furthermore, with the increasing threat of diseases among animals and a surge in demand for quality farm products with low chemical intervention, the animal health market is expected to witness promising demand during the forecast period.

Furthermore, the rising livestock population in the country is also notably augmenting the demand for animal health by the farm sector. According to BPS-Statistics Indonesia, the beef cattle population is highest in the Java region, with 5.05 million head, while in Sumatra, it was 2.81 million, the second-highest beef cattle population in 2024.

Indonesia Animal Health Market Key Products

• APOQUEL: Apoquel is a Zoetis oral tablet for dogs containing oclacitinib maleate, designed to control pruritus linked to allergic dermatitis and manage atopic dermatitis symptoms.
• FELOCELL 3 and FELOCELL 4: Felocell 3 and Felocell 4 are freeze-dried vaccines for cats that protect against feline rhinotracheitis, calicivirus, panleukopenia, and chlamydia.

Indonesia Animal Health Market Segmentation:

By Type

• Vaccines
• Pharmaceuticals
• Feed Additives
• Others

By Animal Type

• Companion Animal
• Production Animal

By End-User

• Vet Hospitals And Clinics
• Animal Farms
• Others

Table Of Contents

1. Executive Summary

2. Market Snapshot

2.1. Market Overview

2.2. Market Definition

2.3. Scope of the Study

2.4. Market Segmentation

3. Business Landscape

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities

3.4. Porter’s Five Forces Analysis

3.5. Industry Value Chain Analysis

3.6. Policies and Regulations

3.7. Strategic Recommendations

4. Technological Outlook

5. Indonesia Animal Health Market By Type 

5.1. Introduction

5.2. Vaccines

5.3. Pharmaceuticals

5.4. Feed Additives

5.5. Others

6. Indonesia Animal Health Market By Animal Type

6.1. Introduction

6.2. Companion Animal

6.3. Production Animal

7. Indonesia Animal Health Market By End User

7.1. Introduction

7.2. Vet Hospitals and Clinics

7.3. Animal Farms

7.4. Others

8. Competitive Environment and Analysis

8.1. Major Players and Strategy Analysis

8.2. Market Share Analysis

8.3. Mergers, Acquisitions, Agreements, and Collaborations

8.4. Competitive Dashboard

9. Company Profiles

9.1. Zoetis Inc.

9.2. Merck & Co., Inc.

9.3. Vetoquinol

9.4. Elanco Animal Health Incorporated.

9.5. ECO Animal Health Group plc

9.6. Ceva Santé Animale

9.7. Virbac

9.8. IDEXX Laboratories, Inc.

9.9. Phibro Animal Health Corporation

9.10. Boehringer Ingelheim

10. Research Methodology

Companies Profiled

Zoetis Inc.

Merck & Co., Inc.

Vetoquinol

Elanco

Bayer AG

ceva Santé Animale

Virbac

IDEXX Laboratories

Phibro Animal Health

Boehringer Ingelheim

Related Reports